In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 70-74

  Alonso, Angelika ^a   Dempfle, Carl Erik ^a   Della Martina, Alberto ^b   Stroick, Mark ^a   Fatar, Marc ^a   Zohsel, Katrin ^a   Allémann, Eric ^b   Hennerici, Michael G ^a   Meairs, Stephen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Abciximab; D dimer; Microbubbles; Thrombolysis; Ultrasound

Indexed keywords

ABCIXIMAB; D DIMER; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; BLOOD LEVEL; BLOOD SAMPLING; CATHETER; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTERNAL CAROTID ARTERY; HISTOLOGY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; THROMBUS; ULTRASOUND;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MICROBUBBLES; RATS; RATS, WISTAR; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONICS;

EID: 64649087020     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.019     Document Type: Article

References (23)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 24 (1995) 1581-1587
2. Wahlgren N., Ahmed N., Davalos A., Ford G.A., Grond M., Hacke W., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369 9558 (2007) 275-282
3. Blinc A., Francis C.W., Trudnowski J.L., and Carstensen E.L. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 81 10 (1993) 2636-2643
4. Pfaffenberger S., Devcic-Kuhar B., El Rabadi K., Groschl M., Speidl W.S., Weiss T.W., et al. 2 MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves. Thromb Haemost 89 3 (2003) 583-589
5. Alexandrov A.V., Molina C.A., Grotta J.C., Garami Z., Ford S.R., Alvarez-Sabin J., et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 21 (2004) 2170-2178
6. Eggers J., Koch B., Meyer K., Konig I., and Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 53 6 (2003) 797-800
7. Tachibana K., and Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 92 5 (1995) 1148-1150
8. Culp W.C., Porter T.R., McCowan T.C., Roberson P.K., James C.A., Matchett W.J., et al. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol 14 3 (2003) 343-347
9. Miller M.W., Miller D.L., and Brayman A.A. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 22 9 (1996) 1131-1154
10. Datta S., Coussios C.C., McAdory L.E., Tan J., Porter T., De Court, et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 32 8 (2006) 1257-1267
11. Stroick M., Alonso A., Fatar M., Griebe M., Kreisel S., Kern R., et al. Effects of simultaneous application of ultrasound and microbubbles on intracerebral hemorrhage in an animal model. Ultrasound Med Biol 32 9 (2006) 1377-1382
12. Fatar M., Stroick M., Griebe M., Alonso A., Kreisel S., Kern R., et al. Effect of combined ultrasound and microbubbles treatment in an experimental model of cerebral ischemia. Ultrasound Med Biol 34 9 (2008) 1414-1420
13. Culp W.C., Porter T.R., Lowery J., Xie F., Roberson P.K., and Marky L. Intracranial Clot Lysis With Intravenous Microbubbles and Transcranial Ultrasound in Swine. Stroke 35 10 (2004) 2407-2411
14. Alonso A., Della Martina A., Stroick M., Fatar M., Griebe M., Pochon S., et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 38 5 (2007) 1508-1514
15. Francis C.W., Blinc A., Lee S., and Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 21 3 (1995) 419-424
16. Zhang Z., Chopp M., Zhang R.L., and Goussev A. A mouse model of embolic focal cerebral ischemia. J Cereb Blood Flow Metab 17 10 (1997) 1081-1088
17. Sassoli P.M., Emmell E.L., Tam S.H., Trikha M., Zhou Z., Jordan R.E., et al. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis. Thromb Haemost 85 5 (2001) 896-902
18. Birnbaum Y., Luo H., Nagai T., Fishbein M.C., Peterson T.M., Li S., et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 97 2 (1998) 130-134
19. Pfaffenberger S., Devcic-Kuhar B., Kollmann C., Kastl S.P., Kaun C., Speidl W.S., et al. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model. Stroke 36 1 (2005) 124-128
20. Molina C.A., Ribo M., Rubiera M., Montaner J., Santamarina E., Delgado-Mederos R., et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37 2 (2006) 425-429
21. Meairs S., and Dempfle C.E. In vitro models for assessing transcranial ultrasound-enhanced thrombolysis. Stroke 36 5 (2005) 929-930
22. Marsh J.N., Senpan A., Hu G., Scott M.J., Gaffney P.J., Wickline S.A., et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed 2 4 (2007) 533-543
23. Adams Jr. H.P., Effron M.B., Torner J., Davalos A., Frayne J., Teal P., et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 39 1 (2008) 87-99